{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:31:44Z","timestamp":1779377504362,"version":"3.53.1"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p>Repeated asparaginase treatment has been associated with hypersensitivity reactions against the bacterial macromolecule in a considerable number of patients. Immunological reactions may range from anaphylaxis without impairment of serum asparaginase activity to a very fast decline in enzyme activity without any clinical symptoms. Previous investigations on a limited number of patients have shown high interindividual variability of asparaginase activity time courses and hypersensitivity reactions in about 30% of patients during reinduction treatment. Therefore, monitoring of reinduction treatment was performed prospectively in 76 children with newly diagnosed acute lymphoblastic leukaemia (ALL). According to the ALL\u2010Berlin\u2013Frankfurt\u2013M\u00fcnster (BFM) 95 protocol, 10\u2003000\u2003U\/m<jats:sup>2<\/jats:sup> body surface area of native <jats:italic>Escherichia coli<\/jats:italic> asparaginase (Asparaginase medac) was given on d\u20038, 11, 15 and 18. In 45\/76 children, trough and peak activities were determined with every dose, and also on d\u20034 and d\u200311 after the last administration. Data on asparaginase activity were not available from the remaining 31 patients, but information with regard to hypersensitivity reactions only was given. Eighteen out of 76 patients (24%) suffered a clinical hypersensitivity reaction; however, no silent inactivation was observed. Activity in the therapeutic range of greater than 100\u2003U\/l for at least 14\u2003d was determined in 43 of the 45 patients who were analysed for enzyme activity.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.03009.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:37:30Z","timestamp":1047364650000},"page":"794-799","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Pharmacokinetics of native <i>Escherichia coli<\/i> asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL\u2010BFM 95 reinduction treatment"],"prefix":"10.1111","volume":"114","author":[{"given":"Hans\u2010Joachim","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"L\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Bl\u00fctters\u2010Sawatzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"D\u00f6rffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"M\u00fcller\u2010Weihrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans\u2010Georg","family":"Scheel\u2010Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Stahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"L\u00fcmkemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Boos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2089.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.9.1780"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.156.3782.1602"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(69)90041-1"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920701)70:1<201::AID-CNCR2820700131>3.0.CO;2-M"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00131-1"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950220614"},{"key":"e_1_2_6_9_1","first-page":"929","article-title":"Evaluation of l\u2010asparaginase metabolism in animals and man","volume":"30","author":"Cooney D.A.","year":"1970","journal-title":"Cancer Research"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197610)38:4<1843::AID-CNCR2820380463>3.0.CO;2-J"},{"key":"e_1_2_6_11_1","first-page":"356","article-title":"Outcome of advanced stage III\u2010IV lymphoblastic Non\u2010Hodgkin's lymphoma \u2013 a Pediatric Oncology Group (POG) study. SIOP XXIX, Abstract O\u2010140","volume":"29","author":"Desai S.","year":"1997","journal-title":"Medical and Pediatric Oncology"},{"key":"e_1_2_6_12_1","first-page":"1602","article-title":"Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases","volume":"43","author":"Durden D.L.","year":"1983","journal-title":"Cancer Research"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198519040-00017"},{"key":"e_1_2_6_14_1","first-page":"1021","article-title":"l\u2010asparaginase and haemostasis: a Gimema retrospective study on the incidence of thrombosis and haemorrhage in ALL patients","volume":"65","author":"Gugliotta L.","year":"1991","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950030410"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W"},{"key":"e_1_2_6_17_1","first-page":"304","article-title":"Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase therapy","volume":"34","author":"Kurtzberg J.","year":"1993","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02187.x"},{"key":"e_1_2_6_19_1","first-page":"127","article-title":"Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL","volume":"81","author":"Nowak\u2010G\u00f6ttl U.","year":"1996","journal-title":"Haematologica"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197208)30:2<376::AID-CNCR2820300212>3.0.CO;2-4"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1046608"},{"key":"e_1_2_6_22_1","first-page":"4554","article-title":"l\u2010asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans","volume":"41","author":"Riccardi R.","year":"1981","journal-title":"Cancer Research"},{"key":"e_1_2_6_23_1","first-page":"5601","article-title":"Influence of intensive asparaginase in the treatment of childhood non\u2010T\u2010cell acute lymphoblastic leukemia","volume":"43","author":"Sallan S.E.","year":"1983","journal-title":"Cancer Research"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1046607"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-119-30169"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01192.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60377-8_81"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.03009.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.03009.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.03009.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T15:00:59Z","timestamp":1697554859000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.03009.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1046\/j.1365-2141.2001.03009.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.03009.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}